Key result
Removal of a large intron region and an 85-nucleotide 3' exon region from influenza virus NS1 mRNA alleviated a block in splicing, increasing splicing efficiency to 48% compared to undetectable levels in intact mRNA.
Identifies specific intron and exon regions in influenza virus NS1 mRNA that inhibit splicing.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in animal models; leaves open whether NS1 region targeting could inform antiviral strategies without supporting clinical use.
In in vitro splicing reactions, influenza virus NS1 mRNA was not detectably spliced, but nonetheless very efficiently formed ATP-dependent 55S complexes containing the U1, U2, U4, U5, and U6 small nuclear ribonucleoproteins (snRNPs) (C. H. Agris, M. E. Nemeroff, and R. M. Krug, Mol. Cell. Biol. 9:259-267, 1989). We demonstrate that the block in splicing was caused by two regions in NS1 mRNA: (i) a large intron region (not including the branchpoint sequence) and (ii) an 85-nucleotide 3' exon region near the 3' end of the exon. After removal of both of these regions, the 5' and 3' splice sites and branchpoint of NS1 mRNA functioned efficiently in splicing, indicating that they were not defective. The two inhibitory regions shared one property: splicing inhibition was independent of the identity of the nucleotide sequence in either region. In other respects, however, the two inhibitory regions differed. The inhibitory activity of the intron region was proportional to its length, indicating that the inhibition was probably due to size only. In contrast, the 3' exon, which was of small size, was a context element; i.e., it functioned only when it was located at a specific position in the 3' exon of NS1 mRNA. To determine how these intron and exon regions inhibited splicing, we compared the types of splicing complexes formed by intact NS1 mRNA with those formed by spliceable NS1 mRNA lacking the intron and exon regions. Splicing complexes were formed by using purified splicing factors.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Nemeroff et al. (1992) studied Influenza Virus NS1 mRNA splicing (in vitro). Deletion of intron and 3' exon regions in NS1 mRNA vs. Intact wild-type NS1 mRNA was evaluated on In vitro splicing efficiency. Removal of a large intron region and an 85-nucleotide 3' exon region from influenza virus NS1 mRNA alleviated a block in splicing, increasing splicing efficiency to 48% compared to undetectable levels in intact mRNA.
Synapse has enriched 10 related papers. Consider them for comparative context: